Effective management of patients with type 2 diabetes following acute coronary syndromes requires aggressive multidisciplinary efforts for risk factor reduction, including meticulous blood glucose control.
Supports multidisciplinary risk factor control in T2DM post-ACS; leaves open optimal targets for prospective trials.
Acute coronary syndromes are associated with a high risk for subsequent major cardiovascular events and with a risk for mortality that remains substantially increased for many months following the acute phase. Patients with type 2 diabetes mellitus are especially vulnerable and encounter excessive long-term mortality. Effective management of patients with type 2 diabetes following acute coronary syndromes requires aggressive multidisciplinary efforts for reduction of several risk factors, including meticulous control of blood glucose. The evidence for different medication and treatment strategies capable of improving the outcomes is reviewed and the currently available recommendations are summarised.
No takes yet. Share an insight, caveat, or question.
Bartnik et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: